Several mechanisms of tolerance have been revealed in experimental models and cancer patients as well, e.g. the effect of tolerogenic dendritic cells expressing indoleamine 2,3-dehydrogenase (IDO), or that of Tregs shown to accumulate in TDLNs [9]. Here, IDO1 is linked to cancer.